fundvisualizer.com

Mesirow Small Company InvestorMSVVX

Performance (before sales charge)

As of 09/30/2024

All information is historical and not indicative of future results. Current performance may be lower or higher than the quoted past performance, which cannot guarantee results. Share price, principal value, and return will vary, and you may have a gain or a loss when you sell your shares. Performance assumes reinvestment of distributions and does not account for taxes. After-sales-charge returns reflect the maximum sales charge applicable to the fund. Performance may not reflect any expense limitation or subsidies currently in effect. Short-term trading fees may apply. To obtain the most recent month-end performance, visit Morningstar.com.

Asset allocation

As of 06/30/2024
Stock
96.22%
Non-U.S. Stock
0.05%
Bond
0.00%
Non-U.S. Bond
0.00%
Preferred
0.00%
Convertible
0.00%
Cash
3.73%
Other
0.00%

Due to rounding, percentages may not equal 100%.

Sectors

As of 06/30/2024

Basic materials

4.62%

Consumer cyclical

8.50%

Financial services

12.47%

Real estate

6.64%

Consumer defensive

5.43%

Health care

15.10%

Utilities

1.85%

Communication services

1.25%

Energy

5.80%

Industrials

18.93%

Technology

14.17%

Top 10 holdings

As of 06/30/2024

Cash & Cash Equivalents
3.73%
ADMA Biologics Inc
1.92%
Fluor Corp
1.80%
Halozyme Therapeutics Inc
1.64%
Catalyst Pharmaceuticals Inc
1.63%
Boston Beer Co Inc Class A
1.57%
Globus Medical Inc Class A
1.56%
CACI International Inc Class A
1.51%
SPDR® S&P Biotech ETF
1.51%
The Brink's Co
1.51%
Fund assets

$32.73 Million

Share class

Inv

Morningstar category

Small Blend

Expense ratio

1.23%

Investment objective

Small Company

Documents